Entity Common Stock, Shares Outstanding of Telix Pharmaceuticals Ltd from 31 Dec 2024 to 31 Dec 2025

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Telix Pharmaceuticals Ltd quarterly Entity Common Stock, Shares Outstanding in shares history and change rate from 31 Dec 2024 to 31 Dec 2025.
  • Telix Pharmaceuticals Ltd Entity Common Stock, Shares Outstanding for the quarter ending 31 Dec 2025 was 338,777,049, a 1.2% increase year-over-year.
Source SEC data
View on sec.gov
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Change (%)

Telix Pharmaceuticals Ltd Quarterly Entity Common Stock, Shares Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 338,777,049 +4,052,564 +1.2% 31 Dec 2025 20-F 20 Feb 2026 2025 FY
Q4 2024 334,724,485 31 Dec 2024 20-F 24 Feb 2025 2024 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.